메뉴 건너뛰기




Volumn 14, Issue 12, 2018, Pages

Vectored delivery of anti-SIV envelope targeting mAb via AAV8 protects rhesus macaques from repeated limiting dose intrarectal swarm SIVsmE660 challenge

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; FIDANACOGENE ELAPARVOVEC; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; ITS01; ITS06.02; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS VECTOR; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

EID: 85058728807     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1007395     Document Type: Article
Times cited : (39)

References (67)
  • 1
    • 85045850427 scopus 로고    scopus 로고
    • Passive immunotherapy of viral infections: “super-antibodies” enter the fray
    • pmid:29379211
    • Walker LM, Burton DR, Passive immunotherapy of viral infections: “super-antibodies” enter the fray. Nat Rev Immunol. Nature Publishing Group; 2018; doi: 10.1038/nri.2017.148 pmid: 29379211
    • (2018) Nat Rev Immunol. Nature Publishing Group
    • Walker, L.M.1    Burton, D.R.2
  • 2
    • 85045841784 scopus 로고    scopus 로고
    • Monoclonal Antibodies for Emerging Infectious Diseases—Borrowing from History
    • pmid:29513615
    • Marston HD, Paules CI, Fauci AS, Monoclonal Antibodies for Emerging Infectious Diseases—Borrowing from History. N Engl J Med. 2018; 1–4. doi: 10.1056/NEJMp1802256 pmid: 29513615
    • (2018) N Engl J Med , pp. 1-4
    • Marston, H.D.1    Paules, C.I.2    Fauci, A.S.3
  • 3
    • 85042287795 scopus 로고    scopus 로고
    • Antibody therapies for the prevention and treatment of viral infections
    • pmid:29263875
    • Salazar G, Zhang N, Fu T-M, An Z, Antibody therapies for the prevention and treatment of viral infections. NPJ vaccines. Springer US; 2017;2: 19. doi: 10.1038/s41541-017-0019-3 pmid: 29263875
    • (2017) NPJ vaccines. Springer US , vol.2 , pp. 19
    • Salazar, G.1    Zhang, N.2    Fu, T.-M.3    An, Z.4
  • 4
    • 77953655955 scopus 로고    scopus 로고
    • Industrialization of mAb production technology: the bioprocessing industry at a crossroads
    • pmid:20065641
    • Kelley B, Industrialization of mAb production technology: the bioprocessing industry at a crossroads. MAbs. 2009;1: 443–52. doi: 10.4161/mabs.1.5.9448 pmid: 20065641
    • (2009) MAbs , vol.1 , pp. 443-452
    • Kelley, B.1
  • 5
    • 85033479478 scopus 로고    scopus 로고
    • Evolving trends in mAb production processes
    • pmid:29313024
    • Shukla AA, Wolfe LS, Mostafa SS, Norman C, Evolving trends in mAb production processes. Bioeng Transl Med. 2017;2: 58–69. doi: 10.1002/btm2.10061 pmid: 29313024
    • (2017) Bioeng Transl Med , vol.2 , pp. 58-69
    • Shukla, A.A.1    Wolfe, L.S.2    Mostafa, S.S.3    Norman, C.4
  • 6
    • 84954445565 scopus 로고    scopus 로고
    • Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection
    • pmid:26702094
    • Lynch RM, Boritz E, Coates EE, Dezure A, Madden P, Costner P, et al. Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection. Sci Transl Med. 2015;7: 319ra206—319ra206. doi: 10.1126/scitranslmed.aad5752 pmid: 26702094
    • (2015) Sci Transl Med , vol.7 , pp. 319ra206
    • Lynch, R.M.1    Boritz, E.2    Coates, E.E.3    Dezure, A.4    Madden, P.5    Costner, P.6
  • 7
    • 84946480939 scopus 로고    scopus 로고
    • Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults
    • pmid:26332605
    • Ledgerwood JE, Coates EE, Yamshchikov G, Saunders JG, Holman L, Enama ME, et al. Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults. Clin Exp Immunol. 2015;182: 289–301. doi: 10.1111/cei.12692 pmid: 26332605
    • (2015) Clin Exp Immunol , vol.182 , pp. 289-301
    • Ledgerwood, J.E.1    Coates, E.E.2    Yamshchikov, G.3    Saunders, J.G.4    Holman, L.5    Enama, M.E.6
  • 8
    • 84992559547 scopus 로고    scopus 로고
    • Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applications
    • pmid:27622299
    • Sparrow E, Friede M, Sheikh M, Torvaldsen S, Newall AT, Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applications. Vaccine. The Authors; 2016;34: 5442–5448. doi: 10.1016/j.vaccine.2016.08.057 pmid: 27622299
    • (2016) Vaccine. The Authors , vol.34 , pp. 5442-5448
    • Sparrow, E.1    Friede, M.2    Sheikh, M.3    Torvaldsen, S.4    Newall, A.T.5
  • 9
    • 85041611031 scopus 로고    scopus 로고
    • Development of anti-drug antibodies is associated with shortened survival in patients with metastatic melanoma treated with ipilimumab
    • pmid:29721387
    • Kverneland AH, Enevold C, Donia M, Bastholt L, Svane IM, Nielsen CH, Development of anti-drug antibodies is associated with shortened survival in patients with metastatic melanoma treated with ipilimumab. Oncoimmunology. Taylor & Francis; 2018; e1424674. doi: 10.1080/2162402X.2018.1424674 pmid: 29721387
    • (2018) Oncoimmunology. Taylor & Francis , pp. e1424674
    • Kverneland, A.H.1    Enevold, C.2    Donia, M.3    Bastholt, L.4    Svane, I.M.5    Nielsen, C.H.6
  • 10
    • 0037434552 scopus 로고    scopus 로고
    • Influence of immunogenicity on the long-term efficacy of infliximab in Crohn’s disease
    • pmid:12584368
    • Baert F, Noman M, Vermeire S, Van Assche G, D’Haens G, Carbonez A, et al. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn’s disease. N Engl J Med. 2003;348: 601–8. doi: 10.1056/NEJMoa020888 pmid: 12584368
    • (2003) N Engl J Med , vol.348 , pp. 601-608
    • Baert, F.1    Noman, M.2    Vermeire, S.3    Van Assche, G.4    D’Haens, G.5    Carbonez, A.6
  • 11
    • 79960935860 scopus 로고    scopus 로고
    • Influence of immunogenicity on the efficacy of long-term treatment with infliximab in rheumatoid arthritis
    • pmid:21427177
    • Pascual-Salcedo D, Plasencia C, Ramiro S, Nuño L, Bonilla G, Nagore D, et al. Influence of immunogenicity on the efficacy of long-term treatment with infliximab in rheumatoid arthritis. Rheumatology (Oxford). 2011;50: 1445–52. doi: 10.1093/rheumatology/ker124 pmid: 21427177
    • (2011) Rheumatology (Oxford) , vol.50 , pp. 1445-1452
    • Pascual-Salcedo, D.1    Plasencia, C.2    Ramiro, S.3    Nuño, L.4    Bonilla, G.5    Nagore, D.6
  • 12
    • 33644820684 scopus 로고    scopus 로고
    • Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response
    • pmid:16474400
    • Manno CS, Pierce GF, Arruda VR, Glader B, Ragni M, Rasko JJ, et al. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med. 2006;12: 342–7. doi: 10.1038/nm1358 pmid: 16474400
    • (2006) Nat Med , vol.12 , pp. 342-347
    • Manno, C.S.1    Pierce, G.F.2    Arruda, V.R.3    Glader, B.4    Ragni, M.5    Rasko, J.J.6
  • 13
    • 84855161388 scopus 로고    scopus 로고
    • Adenovirus-associated virus vector-mediated gene transfer in hemophilia B
    • pmid:22149959
    • Nathwani AC, Tuddenham EGD, Rangarajan S, Rosales C, McIntosh J, Linch DC, et al. Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med. 2011;365: 2357–65. doi: 10.1056/NEJMoa1108046 pmid: 22149959
    • (2011) N Engl J Med , vol.365 , pp. 2357-2365
    • Nathwani, A.C.1    Tuddenham, E.G.D.2    Rangarajan, S.3    Rosales, C.4    McIntosh, J.5    Linch, D.C.6
  • 14
    • 85038006730 scopus 로고    scopus 로고
    • Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant
    • pmid:29211678
    • George LA, Sullivan SK, Giermasz A, Rasko JEJ, Samelson-Jones BJ, Ducore J, et al. Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant. N Engl J Med. 2017;377: 2215–2227. doi: 10.1056/NEJMoa1708538 pmid: 29211678
    • (2017) N Engl J Med , vol.377 , pp. 2215-2227
    • George, L.A.1    Sullivan, S.K.2    Giermasz, A.3    Rasko, J.E.J.4    Samelson-Jones, B.J.5    Ducore, J.6
  • 15
    • 84875962928 scopus 로고    scopus 로고
    • Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPL S447X) gene therapy for lipoprotein lipase deficiency: An open-label trial
    • pmid:22717743
    • Gaudet D, Méthot J, Déry S, Brisson D, Essiembre C, Tremblay G, et al. Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPL S447X) gene therapy for lipoprotein lipase deficiency: An open-label trial. Gene Ther. 2013;20: 361–369. doi: 10.1038/gt.2012.43 pmid: 22717743
    • (2013) Gene Ther , vol.20 , pp. 361-369
    • Gaudet, D.1    Méthot, J.2    Déry, S.3    Brisson, D.4    Essiembre, C.5    Tremblay, G.6
  • 16
    • 84936935341 scopus 로고    scopus 로고
    • Engineering humoral immunity as prophylaxis or therapy
    • pmid:26183209
    • Deal CE, Balazs AB, Engineering humoral immunity as prophylaxis or therapy. Curr Opin Immunol. Elsevier Ltd; 2015;35: 113–122. doi: 10.1016/j.coi.2015.06.014 pmid: 26183209
    • (2015) Curr Opin Immunol. Elsevier Ltd , vol.35 , pp. 113-122
    • Deal, C.E.1    Balazs, A.B.2
  • 17
    • 84871195605 scopus 로고    scopus 로고
    • Antibody gene transfer for HIV immunoprophylaxis
    • pmid:23238748
    • Balazs AB, West AP, Antibody gene transfer for HIV immunoprophylaxis. Nat Immunol. Nature Publishing Group; 2013;14: 1–5. doi: 10.1038/ni.2480 pmid: 23238748
    • (2013) Nat Immunol. Nature Publishing Group , vol.14 , pp. 1-5
    • Balazs, A.B.1    West, A.P.2
  • 18
    • 85010868233 scopus 로고    scopus 로고
    • Antibody gene transfer with adeno-associated viral vectors as a method for HIV prevention
    • pmid:28133808
    • Brady JM, Baltimore D, Balazs AB, Antibody gene transfer with adeno-associated viral vectors as a method for HIV prevention. Immunol Rev. 2017;275: 324–333. doi: 10.1111/imr.12478 pmid: 28133808
    • (2017) Immunol Rev , vol.275 , pp. 324-333
    • Brady, J.M.1    Baltimore, D.2    Balazs, A.B.3
  • 19
    • 84928552521 scopus 로고    scopus 로고
    • Vectored antibody gene delivery for the prevention or treatment of HIV infection
    • Deal CE, Balazs AB, Vectored antibody gene delivery for the prevention or treatment of HIV infection. Curr Opin HIV AIDS. 2015;10: 1–8
    • (2015) Curr Opin HIV AIDS , vol.10 , pp. 1-8
    • Deal, C.E.1    Balazs, A.B.2
  • 20
    • 84893123319 scopus 로고    scopus 로고
    • Safety profile of recombinant adeno-associated viral vectors: focus on alipogene tiparvovec (Glybera)
    • pmid:24308784
    • Salmon F, Grosios K, Petry H, Safety profile of recombinant adeno-associated viral vectors: focus on alipogene tiparvovec (Glybera). Expert Rev Clin Pharmacol. 2014;7: 53–65. doi: 10.1586/17512433.2014.852065 pmid: 24308784
    • (2014) Expert Rev Clin Pharmacol , vol.7 , pp. 53-65
    • Salmon, F.1    Grosios, K.2    Petry, H.3
  • 21
    • 84875962928 scopus 로고    scopus 로고
    • Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial
    • pmid:22717743
    • Gaudet D, Méthot J, Déry S, Brisson D, Essiembre C, Tremblay G, et al. Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial. Gene Ther. Macmillan Publishers Limited; 2013;20: 361–9. doi: 10.1038/gt.2012.43 pmid: 22717743
    • (2013) Gene Ther. Macmillan Publishers Limited , vol.20 , pp. 361-369
    • Gaudet, D.1    Méthot, J.2    Déry, S.3    Brisson, D.4    Essiembre, C.5    Tremblay, G.6
  • 22
    • 85039954002 scopus 로고    scopus 로고
    • AAV5–Factor VIII Gene Transfer in Severe Hemophilia A
    • pmid:29224506, NEJMoa1708483
    • Rangarajan S, Walsh L, Lester W, Perry D, Madan B, Laffan M, et al. AAV5–Factor VIII Gene Transfer in Severe Hemophilia A. N Engl J Med. 2017; NEJMoa1708483. doi: 10.1056/NEJMoa1708483 pmid: 29224506
    • (2017) N Engl J Med
    • Rangarajan, S.1    Walsh, L.2    Lester, W.3    Perry, D.4    Madan, B.5    Laffan, M.6
  • 23
    • 84911383748 scopus 로고    scopus 로고
    • Long-term safety and efficacy of factor IX gene therapy in hemophilia B
    • pmid:25409372
    • Nathwani AC, Reiss UM, Tuddenham EGD, Rosales C, Chowdary P, McIntosh J, et al. Long-term safety and efficacy of factor IX gene therapy in hemophilia B. N Engl J Med. 2014;371: 1994–2004. doi: 10.1056/NEJMoa1407309 pmid: 25409372
    • (2014) N Engl J Med , vol.371 , pp. 1994-2004
    • Nathwani, A.C.1    Reiss, U.M.2    Tuddenham, E.G.D.3    Rosales, C.4    Chowdary, P.5    McIntosh, J.6
  • 24
    • 84861139370 scopus 로고    scopus 로고
    • Gene Therapy for Aromatic L-Amino Acid Decarboxylase Deficiency
    • pmid:22593174
    • Hwu W-L, Muramatsu S -i, Tseng S-H, Tzen K-Y, Lee N-C, Chien Y-H, et al. Gene Therapy for Aromatic L-Amino Acid Decarboxylase Deficiency. Sci Transl Med. 2012;4: 134ra61–134ra61. doi: 10.1126/scitranslmed.3003640 pmid: 22593174
    • (2012) Sci Transl Med , vol.4 , pp. 134ra61
    • Hwu, W.-L.1    Muramatsu, S.I.2    Tseng, S.-H.3    Tzen, K.-Y.4    Lee, N.-C.5    Chien, Y.-H.6
  • 25
    • 84929378811 scopus 로고    scopus 로고
    • Improvement and decline in vision with gene therapy in childhood blindness
    • pmid:25936984
    • Jacobson SG, Cideciyan A V, Roman AJ, Sumaroka A, Schwartz SB, Heon E, et al. Improvement and decline in vision with gene therapy in childhood blindness. N Engl J Med. 2015;372: 1920–6. doi: 10.1056/NEJMoa1412965 pmid: 25936984
    • (2015) N Engl J Med , vol.372 , pp. 1920-1926
    • Jacobson, S.G.1    Cideciyan, A.V.2    Roman, A.J.3    Sumaroka, A.4    Schwartz, S.B.5    Heon, E.6
  • 26
    • 68349150945 scopus 로고    scopus 로고
    • Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys
    • pmid:19448633
    • Johnson PR, Schnepp BC, Zhang J, Connell MJ, Greene SM, Yuste E, et al. Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys. Nat Med. Nature Publishing Group; 2009;15: 901–906. doi: 10.1038/nm.1967 pmid: 19448633
    • (2009) Nat Med. Nature Publishing Group , vol.15 , pp. 901-906
    • Johnson, P.R.1    Schnepp, B.C.2    Zhang, J.3    Connell, M.J.4    Greene, S.M.5    Yuste, E.6
  • 28
    • 84940767753 scopus 로고    scopus 로고
    • AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity
    • pmid:26248318
    • Fuchs SP, Martinez-Navio JM, Piatak M, Lifson JD, Gao G, Desrosiers RC, AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity. PLOS Pathog. 2015;11: e1005090. doi: 10.1371/journal.ppat.1005090 pmid: 26248318
    • (2015) PLOS Pathog , vol.11 , pp. e1005090
    • Fuchs, S.P.1    Martinez-Navio, J.M.2    Piatak, M.3    Lifson, J.D.4    Gao, G.5    Desrosiers, R.C.6
  • 29
    • 84937421013 scopus 로고    scopus 로고
    • Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection
    • pmid:26041300
    • Saunders KO, Wang L, Joyce MG, Yang Z, Balazs AB, Cheng C, et al. Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection. J Virol. 2015;89: 8334–8345. doi: 10.1128/JVI.00908-15 pmid: 26041300
    • (2015) J Virol , vol.89 , pp. 8334-8345
    • Saunders, K.O.1    Wang, L.2    Joyce, M.G.3    Yang, Z.4    Balazs, A.B.5    Cheng, C.6
  • 30
    • 84911476722 scopus 로고    scopus 로고
    • Intramuscular Injection of AAV8 in Mice and Macaques Is Associated with Substantial Hepatic Targeting and Transgene Expression
    • pmid:25393537
    • Greig J a, Peng H, Ohlstein J, Medina-Jaszek CA, Ahonkhai O, Mentzinger A, et al. Intramuscular Injection of AAV8 in Mice and Macaques Is Associated with Substantial Hepatic Targeting and Transgene Expression. PLoS One. 2014;9: e112268. doi: 10.1371/journal.pone.0112268 pmid: 25393537
    • (2014) PLoS One , vol.9 , pp. e112268
    • Greig, J.A.1    Peng, H.2    Ohlstein, J.3    Medina-Jaszek, C.A.4    Ahonkhai, O.5    Mentzinger, A.6
  • 31
    • 84929613728 scopus 로고    scopus 로고
    • Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian/Human Immunodeficiency Virus Infection
    • pmid:25787288
    • Saunders KO, Pegu A, Georgiev IS, Zeng M, Joyce MG, Yang Z-Y, et al. Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian/Human Immunodeficiency Virus Infection. J Virol. 2015;89: 5895–903. doi: 10.1128/JVI.00210-15 pmid: 25787288
    • (2015) J Virol , vol.89 , pp. 5895-5903
    • Saunders, K.O.1    Pegu, A.2    Georgiev, I.S.3    Zeng, M.4    Joyce, M.G.5    Yang, Z.-Y.6
  • 32
    • 84855584286 scopus 로고    scopus 로고
    • The use of nonhuman primate models of HIV infection for the evaluation of antiviral strategies
    • pmid:21902451
    • Van Rompay KKA, The use of nonhuman primate models of HIV infection for the evaluation of antiviral strategies. AIDS Res Hum Retroviruses. United States; 2012;28: 16–35. doi: 10.1089/aid.2011.0234 pmid: 21902451
    • (2012) AIDS Res Hum Retroviruses. United States , vol.28 , pp. 16-35
    • Van Rompay, K.K.A.1
  • 33
    • 84880332648 scopus 로고    scopus 로고
    • Using Nonhuman Primates to Model HIV Transmission
    • pmid:23666391
    • Fennessey CM, Keele BF, Using Nonhuman Primates to Model HIV Transmission. Curr Opin HIV AIDS. 2013;8: 280–287. pmid: 23666391
    • (2013) Curr Opin HIV AIDS , vol.8 , pp. 280-287
    • Fennessey, C.M.1    Keele, B.F.2
  • 34
    • 55849127747 scopus 로고    scopus 로고
    • Macaca mulatta, fascicularis and nemestrina in AIDS vaccine development
    • pmid:18980543
    • Baroncelli S, Negri DRM, Michelini Z, Cara A, Macaca mulatta, fascicularis and nemestrina in AIDS vaccine development. Expert Rev Vaccines. England; 2008;7: 1419–1434. doi: 10.1586/14760584.7.9.1419 pmid: 18980543
    • (2008) Expert Rev Vaccines. England , vol.7 , pp. 1419-1434
    • Baroncelli, S.1    Negri, D.R.M.2    Michelini, Z.3    Cara, A.4
  • 35
    • 84900820250 scopus 로고    scopus 로고
    • Simian-Human Immunodeficiency Viruses and Their Impact on Non-Human Primate Models for AIDS
    • Pereira L, Srinivasan P, Smith J, Simian-Human Immunodeficiency Viruses and Their Impact on Non-Human Primate Models for AIDS. Immunodeficiency. 2012; doi: 10.5772/53556
    • (2012) Immunodeficiency
    • Pereira, L.1    Srinivasan, P.2    Smith, J.3
  • 36
    • 84907983318 scopus 로고    scopus 로고
    • Enhanced neonatal Fc receptor function improves protection against primate SHIV infection
    • pmid:25119033
    • Ko S-Y, Pegu A, Rudicell RS, Yang Z, Joyce MG, Chen X, et al. Enhanced neonatal Fc receptor function improves protection against primate SHIV infection. Nature. Nature Publishing Group; 2014;514: 642–5. doi: 10.1038/nature13612 pmid: 25119033
    • (2014) Nature. Nature Publishing Group , vol.514 , pp. 642-645
    • Ko, S.-Y.1    Pegu, A.2    Rudicell, R.S.3    Yang, Z.4    Joyce, M.G.5    Chen, X.6
  • 38
    • 85042940751 scopus 로고    scopus 로고
    • Intramuscular Adeno-Associated Virus–Mediated Expression of Monoclonal Antibodies Provides 100% Protection Against Ebola Virus Infection in Mice
    • van Lieshout LP, Soule G, Sorensen D, Frost KL, He S, Tierney K, et al. Intramuscular Adeno-Associated Virus–Mediated Expression of Monoclonal Antibodies Provides 100% Protection Against Ebola Virus Infection in Mice. J Infect Dis. 2018; 1–10
    • (2018) J Infect Dis , pp. 1-10
    • van Lieshout, L.P.1    Soule, G.2    Sorensen, D.3    Frost, K.L.4    He, S.5    Tierney, K.6
  • 39
    • 84929613728 scopus 로고    scopus 로고
    • Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian/Human Immunodeficiency Virus Infection
    • pmid:25787288
    • Saunders KO, Pegu A, Georgiev IS, Zeng M, Joyce MG, Yang Z-Y, et al. Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian/Human Immunodeficiency Virus Infection. J Virol. 2015;89: 5895–5903. doi: 10.1128/JVI.00210-15 pmid: 25787288
    • (2015) J Virol , vol.89 , pp. 5895-5903
    • Saunders, K.O.1    Pegu, A.2    Georgiev, I.S.3    Zeng, M.4    Joyce, M.G.5    Yang, Z.-Y.6
  • 40
    • 0013442744 scopus 로고    scopus 로고
    • AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B
    • Manno CS, Chew AJ, Hutchison S, Larson PJ, Herzog RW, Arruda VR, et al. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Analgesia. 2003;101: 2963–2972
    • (2003) Analgesia , vol.101 , pp. 2963-2972
    • Manno, C.S.1    Chew, A.J.2    Hutchison, S.3    Larson, P.J.4    Herzog, R.W.5    Arruda, V.R.6
  • 41
    • 77951916324 scopus 로고    scopus 로고
    • Anti-HIV-1 activity of weekly or biweekly treatment with subcutaneous PRO 140, a CCR5 monoclonal antibody
    • pmid:20377413
    • Jacobson JM, Thompson M a, Lalezari JP, Saag MS, Zingman BS, D’Ambrosio P, et al. Anti-HIV-1 activity of weekly or biweekly treatment with subcutaneous PRO 140, a CCR5 monoclonal antibody. J Infect Dis. 2010;201: 1481–7. doi: 10.1086/652190 pmid: 20377413
    • (2010) J Infect Dis , vol.201 , pp. 1481-1487
    • Jacobson, J.M.1    Thompson, M.A.2    Lalezari, J.P.3    Saag, M.S.4    Zingman, B.S.5    D’Ambrosio, P.6
  • 42
    • 0141514408 scopus 로고    scopus 로고
    • DNA vaccine strategies: Candidates for immune modulation and immunization regimens
    • pmid:14511953
    • Doria-Rose NA, Haigwood NL, DNA vaccine strategies: Candidates for immune modulation and immunization regimens. Methods. 2003;31: 207–216. doi: 10.1016/S1046-2023(03)00135-X pmid: 14511953
    • (2003) Methods , vol.31 , pp. 207-216
    • Doria-Rose, N.A.1    Haigwood, N.L.2
  • 43
    • 57549090220 scopus 로고    scopus 로고
    • Intramuscular administration of AAV1-lipoprotein lipaseS447X lowers triglycerides in lipoprotein lipase-deficient patients
    • pmid:18802015
    • Stroes ES, Nierman MC, Meulenberg JJ, Franssen R, Twisk J, Henny CP, et al. Intramuscular administration of AAV1-lipoprotein lipaseS447X lowers triglycerides in lipoprotein lipase-deficient patients. Arterioscler Thromb Vasc Biol. 2008;28: 2303–2304. doi: 10.1161/ATVBAHA.108.175620 pmid: 18802015
    • (2008) Arterioscler Thromb Vasc Biol , vol.28 , pp. 2303-2304
    • Stroes, E.S.1    Nierman, M.C.2    Meulenberg, J.J.3    Franssen, R.4    Twisk, J.5    Henny, C.P.6
  • 44
    • 84878746264 scopus 로고    scopus 로고
    • Pre-existing Anti–Adeno-Associated Virus Antibodies as a Challenge in AAV Gene Therapy
    • pmid:23442094
    • Louis Jeune V, Joergensen JA, Hajjar RJ, Weber T, Pre-existing Anti–Adeno-Associated Virus Antibodies as a Challenge in AAV Gene Therapy. Hum Gene Ther Methods. 2013;24: 59–67. doi: 10.1089/hgtb.2012.243 pmid: 23442094
    • (2013) Hum Gene Ther Methods , vol.24 , pp. 59-67
    • Louis Jeune, V.1    Joergensen, J.A.2    Hajjar, R.J.3    Weber, T.4
  • 45
    • 84877930020 scopus 로고    scopus 로고
    • Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells
    • pmid:23325831
    • Martino AT, Basner-Tschakarjan E, Markusic DM, Finn JD, Hinderer C, Zhou S, et al. Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells. Blood. 2013;121: 2224–2233. doi: 10.1182/blood-2012-10-460733 pmid: 23325831
    • (2013) Blood , vol.121 , pp. 2224-2233
    • Martino, A.T.1    Basner-Tschakarjan, E.2    Markusic, D.M.3    Finn, J.D.4    Hinderer, C.5    Zhou, S.6
  • 46
    • 85031746439 scopus 로고    scopus 로고
    • Bioengineered AAV Capsids with Combined High Human Liver Transduction In Vivo and Unique Humoral Seroreactivity
    • pmid:29055620
    • Paulk NK, Pekrun K, Zhu E, Nygaard S, Li B, Xu J, et al. Bioengineered AAV Capsids with Combined High Human Liver Transduction In Vivo and Unique Humoral Seroreactivity. Mol Ther. Elsevier Ltd.; 2018;26: 289–303. doi: 10.1016/j.ymthe.2017.09.021 pmid: 29055620
    • (2018) Mol Ther. Elsevier Ltd. , vol.26 , pp. 289-303
    • Paulk, N.K.1    Pekrun, K.2    Zhu, E.3    Nygaard, S.4    Li, B.5    Xu, J.6
  • 47
    • 84947022242 scopus 로고    scopus 로고
    • In silico reconstruction of the viral evolutionary lineage yields a potent gene therapy vector
    • pmid:26235624
    • Zinn E, Pacouret S, Khaychuk V, Turunen HT, Carvalho LS, Andres-Mateos E, et al. In silico reconstruction of the viral evolutionary lineage yields a potent gene therapy vector. Cell Rep. The Authors; 2015;12: 1056–1068. doi: 10.1016/j.celrep.2015.07.019 pmid: 26235624
    • (2015) Cell Rep. The Authors , vol.12 , pp. 1056-1068
    • Zinn, E.1    Pacouret, S.2    Khaychuk, V.3    Turunen, H.T.4    Carvalho, L.S.5    Andres-Mateos, E.6
  • 48
    • 85016568747 scopus 로고    scopus 로고
    • The Immunoregulatory Roles of Antibody Glycosylation
    • pmid:28385520
    • Jennewein MF, Alter G, The Immunoregulatory Roles of Antibody Glycosylation. Trends Immunol. Elsevier Ltd; 2017;38: 358–372. doi: 10.1016/j.it.2017.02.004 pmid: 28385520
    • (2017) Trends Immunol. Elsevier Ltd , vol.38 , pp. 358-372
    • Jennewein, M.F.1    Alter, G.2
  • 49
    • 84962467040 scopus 로고    scopus 로고
    • Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination
    • pmid:26982805
    • Mahan AE, Jennewein MF, Suscovich T, Dionne K, Tedesco J, Chung AW, et al. Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination. PLoS Pathog. 2016;12: 1–18. doi: 10.1371/journal.ppat.1005456 pmid: 26982805
    • (2016) PLoS Pathog , vol.12 , pp. 1-18
    • Mahan, A.E.1    Jennewein, M.F.2    Suscovich, T.3    Dionne, K.4    Tedesco, J.5    Chung, A.W.6
  • 52
    • 34249796660 scopus 로고    scopus 로고
    • The neutralization properties of a HIV-specific antibody are markedly altered by glycosylation events outside the antigen-binding domain
    • pmid:17513762
    • Miranda LR, Duval M, Doherty H, Seaman MS, Posner MR, Cavacini L a, The neutralization properties of a HIV-specific antibody are markedly altered by glycosylation events outside the antigen-binding domain. J Immunol. 2007;178: 7132–8. pmid: 17513762
    • (2007) J Immunol , vol.178 , pp. 7132-7138
    • Miranda, L.R.1    Duval, M.2    Doherty, H.3    Seaman, M.S.4    Posner, M.R.5    Cavacini, L.A.6
  • 53
    • 84992735645 scopus 로고    scopus 로고
    • Modulating Antibody Functionality in Infectious Disease and Vaccination
    • pmid:27756530
    • Gunn BM, Alter G, Modulating Antibody Functionality in Infectious Disease and Vaccination. Trends Mol Med. Elsevier Ltd; 2016;22: 969–982. doi: 10.1016/j.molmed.2016.09.002 pmid: 27756530
    • (2016) Trends Mol Med. Elsevier Ltd , vol.22 , pp. 969-982
    • Gunn, B.M.1    Alter, G.2
  • 54
    • 84896120124 scopus 로고    scopus 로고
    • Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission
    • pmid:24509526
    • Balazs AB, Ouyang Y, Hong CM, Chen J, Nguyen SM, Rao DS, et al. Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission. Nat Med. Nature Publishing Group; 2014;20: 296–300. doi: 10.1038/nm.3471 pmid: 24509526
    • (2014) Nat Med. Nature Publishing Group , vol.20 , pp. 296-300
    • Balazs, A.B.1    Ouyang, Y.2    Hong, C.M.3    Chen, J.4    Nguyen, S.M.5    Rao, D.S.6
  • 55
  • 56
    • 85032818556 scopus 로고    scopus 로고
    • Recent Insights into the HIV/AIDS Pandemic
    • pmid:28357381
    • Becerra JC, Bildstein LS, Gach JS, Recent Insights into the HIV/AIDS Pandemic. Microb Cell. 2016;3: 450–474. pmid: 28357381
    • (2016) Microb Cell , vol.3 , pp. 450-474
    • Becerra, J.C.1    Bildstein, L.S.2    Gach, J.S.3
  • 57
    • 85010902371 scopus 로고    scopus 로고
    • Use of broadly neutralizing antibodies for HIV-1 prevention
    • pmid:28133803
    • Pegu A, Hessell AJ, Mascola JR, Haigwood NL, Use of broadly neutralizing antibodies for HIV-1 prevention. Immunol Rev. 2017;275: 296–312. doi: 10.1111/imr.12511 pmid: 28133803
    • (2017) Immunol Rev , vol.275 , pp. 296-312
    • Pegu, A.1    Hessell, A.J.2    Mascola, J.R.3    Haigwood, N.L.4
  • 58
    • 84879302728 scopus 로고    scopus 로고
    • HIV-1 neutralizing antibodies: understanding nature ‘ s pathways
    • pmid:23772623
    • Mascola JR, Haynes BF, HIV-1 neutralizing antibodies: understanding nature ‘ s pathways. Immunol Rev. 2013;254: 225–244. doi: 10.1111/imr.12075 pmid: 23772623
    • (2013) Immunol Rev , vol.254 , pp. 225-244
    • Mascola, J.R.1    Haynes, B.F.2
  • 59
    • 84964896857 scopus 로고    scopus 로고
    • Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability
    • pmid:27064278
    • Mason RD, Welles HC, Adams C, Chakrabarti BK, Gorman J, Zhou T, et al. Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability. PLoS Pathog. 2016;12. doi: 10.1371/journal.ppat.1005537 pmid: 27064278
    • (2016) PLoS Pathog , vol.12
    • Mason, R.D.1    Welles, H.C.2    Adams, C.3    Chakrabarti, B.K.4    Gorman, J.5    Zhou, T.6
  • 60
    • 84866495323 scopus 로고    scopus 로고
    • Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies
    • pmid:22999947
    • Kwong PD, Mascola JR, Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies. Immunity. Elsevier Inc.; 2012;37: 412–425. doi: 10.1016/j.immuni.2012.08.012 pmid: 22999947
    • (2012) Immunity. Elsevier Inc , vol.37 , pp. 412-425
    • Kwong, P.D.1    Mascola, J.R.2
  • 62
    • 84865737411 scopus 로고    scopus 로고
    • Lower antibody levels to Staphylococcus aureus exotoxins are associated with sepsis in hospitalized adults with invasive S. aureus infections
    • pmid:22807524
    • Adhikari RP, Ajao AO, Aman MJ, Karauzum H, Sarwar J, Lydecker AD, et al. Lower antibody levels to Staphylococcus aureus exotoxins are associated with sepsis in hospitalized adults with invasive S. aureus infections. J Infect Dis. 2012;206: 915–23. doi: 10.1093/infdis/jis462 pmid: 22807524
    • (2012) J Infect Dis , vol.206 , pp. 915-923
    • Adhikari, R.P.1    Ajao, A.O.2    Aman, M.J.3    Karauzum, H.4    Sarwar, J.5    Lydecker, A.D.6
  • 63
    • 84955741596 scopus 로고    scopus 로고
    • Generating Monoclonal Antibodies
    • Greenfield EA, Generating Monoclonal Antibodies. A Labratory Man. 2014; 201–221
    • (2014) A Labratory Man , pp. 201-221
    • Greenfield, E.A.1
  • 64
    • 84904497424 scopus 로고    scopus 로고
    • Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4
    • Pegu A, Yang Z, Boyington JC, Wu L, Ko S, Schmidt SD, et al. Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4receptor. 2014;6
    • (2014) receptor , vol.6
    • Pegu, A.1    Yang, Z.2    Boyington, J.C.3    Wu, L.4    Ko, S.5    Schmidt, S.D.6
  • 65
    • 45849125030 scopus 로고    scopus 로고
    • Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays
    • pmid:18432938
    • Montefiori DC, Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays. Curr Protoc Immunol. 2005;Chapter 12: Unit 12.11. doi: 10.1002/0471142735.im1211s64 pmid: 18432938
    • (2005) Curr Protoc Immunol , vol.Chapter 12 , pp. Unit 12.11
    • Montefiori, D.C.1
  • 66
    • 84940737670 scopus 로고    scopus 로고
    • Parsimonious Determination of the Optimal Infectious Dose of a Pathogen for Nonhuman Primate Models
    • pmid:26285041
    • Roederer M, Parsimonious Determination of the Optimal Infectious Dose of a Pathogen for Nonhuman Primate Models. PLoS Pathog. 2015; 1–14. doi: 10.1371/journal.ppat.1005100 pmid: 26285041
    • (2015) PLoS Pathog , pp. 1-14
    • Roederer, M.1
  • 67
    • 84974718820 scopus 로고    scopus 로고
    • Envelope residue 375 substitutions in simian–human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques
    • pmid:27247400
    • Li H, Wang S, Kong R, Ding W, Lee F-H, Parker Z, et al. Envelope residue 375 substitutions in simian–human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques. Proc Natl Acad Sci. 2016;113: E3413–E3422. doi: 10.1073/pnas.1606636113 pmid: 27247400
    • (2016) Proc Natl Acad Sci , vol.113 , pp. E3413-E3422
    • Li, H.1    Wang, S.2    Kong, R.3    Ding, W.4    Lee, F.-H.5    Parker, Z.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.